Abstract
Background Violence against women and against children are human rights violations with lasting harms to survivors and societies at large. Intimate partner violence (IPV) and sexual violence against children (SVAC) are two major forms of such abuse. Despite their wide-reaching effects on individual and community health, these risk factors have not been adequately prioritised as key drivers of global health burden. Comprehensive x§and reliable estimates of the comparative health burden of IPV and SVAC are urgently needed to inform investments in prevention and support for survivors at both national and global levels. Methods We estimated the prevalence and attributable burden of IPV among females and SVAC among males and females for 204 countries and territories, by age and sex, from 1990 to 2023, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. We searched several global databases for data on self-reported exposure to IPV and SVAC and undertook a systematic review to identify the health outcomes associated with each of these risk factors. We modelled IPV and SVAC prevalence using spatiotemporal Gaussian process regression, applying data adjustments to account for measurement heterogeneity. We employed burden-of-proof methodology to estimate relative risks for outcomes associated with IPV and SVAC. These estimates informed the calculation of population attributable fractions, which were then used to quantify disability-adjusted life-years (DALYs) attributable to each risk factor. Findings Globally, in 2023, we estimated that 608 million (95% uncertainty interval 518–724) females aged 15 years and older had ever been exposed to IPV, and 1·01 billion (0·764–1·48) individuals aged 15 years and older had experienced sexual violence during childhood. 18·5 million (8·74–30·0) DALYs were attributed to IPV among females and 32·2 million (16·4–52·5) DALYs were attributed to SVAC among males and females in 2023. IPV and SVAC were among the top contributors to the global disease burden in 2023, particularly among females aged 15–49 years, ranking as the fourth and fifth leading risk factors, respectively, for DALYs in this group. Among the eight health outcomes found to be associated with IPV, anxiety disorders and major depressive disorder were the leading causes of IPV-attributed DALYs, accounting for 5·43 million (–1·25 to 14·6) and 3·96 million (1·71 to 6·92) DALYs in 2023, respectively. SVAC was associated with 14 health outcomes, including mental health disorder, substance use disorder, and chronic and infectious disease outcomes. Self-harm and schizophrenia were the leading causes of SVAC-attributed burden, with SVAC accounting for 6·71 million (2·00 to 12·7) DALYs due to self-harm and 4·15 million (–1·92 to 13·1) DALYs due to schizophrenia in 2023. Interpretation IPV and SVAC are substantial contributors to global health burden, and their health consequences span a variety of individual health outcomes. Importantly, mental health disorders account for the greatest share of disease burden among survivors. Investing in prevention of these avoidable risk factors has the potential to avert millions of DALYs and considerable premature mortality each year. Our findings represent strong evidence for global and national leaders to elevate IPV and SVAC among public health priorities. Sustained investments are needed to prevent IPV and SVAC and to implement interventions focused on supporting the complex social and health needs of survivors. Funding Gates Foundation.
| Original language | English |
|---|---|
| Pages (from-to) | 31-52 |
| Number of pages | 22 |
| Journal | The Lancet |
| Volume | 407 |
| Issue number | 10523 |
| DOIs | |
| Publication status | Published - 3 Jan 2026 |
ASJC Scopus subject areas
- General Medicine
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet, Vol. 407, No. 10523, 03.01.2026, p. 31-52.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023
T2 - a systematic analysis for the Global Burden of Disease Study 2023
AU - Flor, Luisa S.
AU - Spencer, Cory N.
AU - Cagney, Jack
AU - Gil, Gabriela Fernanda
AU - Aalruz, Hasan
AU - Abd ElHafeez, Samar
AU - Abdelwahab, Siddig Ibrahim
AU - Abdoun, Meriem
AU - Abebe, Mesfin
AU - Abebe, Yonas
AU - Abedi, Armita
AU - Abeldaño Zuñiga, Roberto Ariel
AU - Abie, Alemwork
AU - Abiodun, Olumide
AU - Aboagye, Richard Gyan
AU - Abreu, Lucas Guimarães
AU - Abu Farha, Rana Kamal
AU - Abubakar, Bilyaminu
AU - Abuhammad, Sawsan
AU - Achore, Meshack
AU - Adams, Lisa C.
AU - Adebiyi, Babatope Oluwadamilare
AU - Adedokun, Kamoru Ademola
AU - Adegbile, Oluwatobi E.
AU - Adegoke, Nurudeen A.
AU - Adeleke, Olumide Thomas
AU - Adeniyi, Makinde Adebayo
AU - Adesina, Miracle Ayomikun
AU - Adewuyi, Habeeb Omoponle
AU - Adnani, Qorinah Estiningtyas Sakilah
AU - Adzigbli, Leticia Akua
AU - Afolabi, Aanuoluwapo Adeyimika
AU - Afolabi, Rotimi Felix
AU - Afzal, Muhammad Sohail
AU - Afzal, Saira
AU - Agyemang-Duah, Williams
AU - Ahinkorah, Bright Opoku
AU - Ahmad, Aqeel
AU - Ahmad, Danish
AU - Ahmad, Muayyad M.
AU - Ahmed, Asma
AU - Ahmed, Ayman
AU - Ahmed, Haroon
AU - Ahmed, Mehrunnisha Sharif
AU - Ahmed, Oli
AU - Akin-Odanye, Elizabeth Oluwatoyin
AU - Akosile, Wole
AU - Akpabio, Idorenyin Ubon
AU - Alam, Zufishan
AU - Al-Amer, Rasmieh Mustafa
AU - Alansari, Amani N.
AU - Alanzi, Turki M.
AU - Aleidi, Shereen M.
AU - Alemu, Melaku Birhanu
AU - Alhalaiqa, Fadwa Naji
AU - Al-Iede, Montaha
AU - Alinejad Rokny, Hamid
AU - Almagharbeh, Wesam Taher
AU - Al-Mamun, Md
AU - Almazan, Joseph Uy
AU - Alnaeem, Mohmmad Minwer
AU - Alrimawi, Intima
AU - Alshahrani, Najim Z.
AU - Alyahya, Mohammad Sharif Ibrahim
AU - Amin, Tarek Tawfik
AU - Amini, Saeed
AU - Amiri, Sohrab
AU - Amu, Hubert
AU - Amzat, Jimoh
AU - Anderson, David B.
AU - Anuoluwa, Boluwatife Stephen
AU - Anvari, Saeid
AU - Anyasodor, Anayochukwu Edward
AU - Aravkin, Aleksandr Y.
AU - Arias de la Torre, Jorge
AU - Armocida, Benedetta
AU - Arrieta, Alejandra
AU - Arumuganainar, Deepavalli
AU - Ashraf, Tahira
AU - Aslam, Bilal
AU - Asri, Yuni
AU - Athari, Seyyed Shamsadin
AU - Atorkey, Prince
AU - Atre, Sachin R.
AU - Atsbaha, Abadi Hailay
AU - Atta, Julie Alaere
AU - Atteraya, Madhu Sudhan
AU - Azzam, Ahmed Y.
AU - Sheeba, B.
AU - Baghlaf, Khlood K.
AU - Baig, Atif Amin
AU - Balcha, Wondu Feyisa
AU - Balmori-de-la-Miyar, Jose
AU - Bandyopadhyay, Soham
AU - Barik, Manish
AU - Barker-Collo, Suzanne Lyn
AU - Bashar, MD Abu
AU - Bashir, Shahid
AU - Bashiri, Azadeh
AU - Bastan, Mohammad Mahdi
AU - Beeraka, Narasimha M.
AU - Belayneh, Melesse
AU - Belge Bilgin, Gokce
AU - Bell, Michelle L.
AU - Berihun, Abiye Assefa
AU - Bermudez, Amiel Nazer C.
AU - Bhatnagar, Arushee
AU - Bhattarai, Ashmin Hari
AU - Biswas, Mohammad Shahangir
AU - Bjertness, Espen
AU - Bolarinwa, Obasanjo Afolabi
AU - Bolourinejad, Paria
AU - Boppana, Sri Harsha
AU - Botero Carvajal, Alejandro
AU - Bouaoud, Souad
AU - Brugha, Traolach
AU - Buonsenso, Danilo
AU - Burns, Richard A.
AU - Bustanji, Yasser
AU - Carugno, Andrea
AU - Carvalho, Andre F.
AU - Carvalho, Felix
AU - Castaldelli-Maia, Joao Mauricio
AU - Cerrai, Sonia
AU - Chandan, Joht Singh
AU - Chandradasa, Miyuru
AU - Charalampous, Periklis
AU - Chattu, Vijay Kumar
AU - Chaudhary, Anis Ahmad
AU - Chaudhuri, Sirshendu
AU - Chen, Haiyan
AU - Ching, Patrick R.
AU - Chopra, Hitesh
AU - Chukwu, Chidozie Williams
AU - Chukwu, Isaac Sunday
AU - Chung, Sunghyun
AU - Cullen, Patricia
AU - da Silva, Alanna Gomes
AU - Dachew, Berihun Assefa
AU - Dadras, Omid
AU - Dai, Xiaochen
AU - Dalal, Koustuv
AU - Dandona, Rakhi
AU - D'Anna, Lucio
AU - Darcho, Samuel Demissie
AU - Dayal, Harsha
AU - DeGraw, Erin M.
AU - Dellie, Endalkachew
AU - Deuba, Keshab
AU - Dewan, Syed Masudur Rahman
AU - Dias da Silva, Diana
AU - Diaz, Daniel
AU - Dohare, Sushil
AU - Dowou, Robert Kokou
AU - Dumbili, Emeka W.
AU - Dunne, Jennifer
AU - Eboreime, Ejemai
AU - Edeh, Cynthia
AU - Edinur, Hisham Atan
AU - Ekholuenetale, Michael
AU - El Morsi, Doaa Abdel Wahab
AU - Eshun, Gilbert
AU - Fagbamigbe, Adeniyi Francis
AU - Fan, Qiping
AU - Farahani, Alireza
AU - Faro, Andre
AU - Fasanmi, Abidemi Omolara
AU - Feizkhah, Alireza
AU - Ferreira, Nuno
AU - Franklin, Richard Charles
AU - Fry, Deborah Ann
AU - Gao, Xiang
AU - Gebregergis, Miglas Welay
AU - Gebrehiwot, Mesfin
AU - Geda, Yohannes Fikadu
AU - Gelchu, Miesa
AU - Getahun, Genanew K.
AU - Ghasemi Assl, Shakiba
AU - Gholami, Ehsan
AU - Gholizadeh, Nasim
AU - Ghotbi, Elena
AU - Gilani, Jaleed Ahmed
AU - Girmay, Alem Abera
AU - Golechha, Mahaveer
AU - Goleij, Pouya
AU - Grivna, Michal
AU - Guan, Shi Yang
AU - Gunawardane, Damitha Asanga
AU - Gupta, Sapna
AU - Halder, Pritam
AU - Halil, Hassen Mosa
AU - Hanif, Asif
AU - Hanifi, Nasrin
AU - Hareru, Habtamu Endashaw
AU - Haro, Josep Maria
AU - Has, Eka Mishbahatul Marah
AU - Hasaballah, Ahmed I.
AU - Hasani, Hamidreza
AU - Hay, Simon I.
AU - Herbert, Molly E.
AU - Hesari, Marjan
AU - Hlongwa, Mbuzeleni
AU - Hossain, Mazeda
AU - Hossain, Md Mahbub
AU - Hossain, Md Sabbir
AU - Hossain, Mohammad Bellal
AU - Hu, Chengxi
AU - Huang, Junjie
AU - Huang, Yongsong
AU - Iftikhar, Pulwasha Maria
AU - Iqbal, Meesha
AU - Irham, Lalu Muhammad
AU - Iskander, Teresa R.
AU - Islam, Md Shahinul
AU - Islam, Sheikh Mohammed Shariful
AU - Jabbarinejad, Roxana
AU - Jena, Belayneh Hamdela
AU - Jha, Ravi Prakash
AU - Joseph, Nitin
AU - Joshua, Charity Ehimwenma
AU - Kang, Jiseung
AU - Kanmodi, Kehinde Kazeem
AU - Karajizadeh, Mehrdad
AU - Karami, Jafar
AU - Kashoo, Faizan Zaffar
AU - Khaing, Inn Kynn
AU - Khajuria, Himanshu
AU - Khalil, Mariam
AU - Khan, Iqra Hamid
AU - Khan, Ramsha Mushtaq
AU - Khanmohammadi, Shaghayegh
AU - Khasbage, Sameer Uttamaro
AU - Kheirallah, Khalid A.
AU - Khoshvaght, Samira
AU - Khosrowjerdi, Mahmood
AU - Khubchandani, Jagdish
AU - Kim, Jinho
AU - Kim, Kwanghyun
AU - Knaul, Felicia Marie
AU - Knudsen, Ann Kristin Skrindo
AU - Koomson-Yalley, Elizabeth
AU - Kretchy, Irene Akwo
AU - Krishan, Kewal
AU - Kuate Defo, Barthelemy
AU - Kuddus, Mohammed
AU - Kuitunen, Ilari
AU - Kulimbet, Mukhtar
AU - Kumar, Dewesh
AU - Kumar, G. Anil
AU - Kumar, Kamal
AU - Kumar, Manasi
AU - Kumar, Rakesh
AU - Kumar, Vijay
AU - Kusi Amponsah, Abigail
AU - Kusnali, Asep
AU - Kuwornu, John Paul
AU - Kyei-Arthur, Frank
AU - Pallavi, L. C.
AU - Laflamme, Lucie
AU - Lahariya, Chandrakant
AU - Lajunen, Timo
AU - Langguth, Berthold
AU - Laslett, Anne Marie
AU - Lassi, Zohra S.
AU - Latif, Areeba
AU - Lawal, Saheed Akinmayowa
AU - Lawan, Aliyu
AU - Lee, Seung Won
AU - Leshargie, Cheru Tesema
AU - Li, Jie
AU - Li, Zhihui
AU - Liu, Jue
AU - Liu, Xuefeng
AU - Llanaj, Erand
AU - Loreche, Arianna Maever
AU - Ma, Kevin Sheng Kai
AU - Ma, Zheng Feei
AU - Madadizadeh, Farzan
AU - Madureira-Carvalho, Aurea Marilia
AU - Mahmood, Nozad Hussein
AU - Makram, Abdelrahman M.
AU - Mallick, Trisha
AU - Malta, Deborah Carvalho
AU - Manjani, Lokesh
AU - Maravilla, Joemer C.
AU - Marzouk, Sammer
AU - Matei, Clara N.
AU - Mathangasinghe, Yasith
AU - Mattoo, Khurshid A.
AU - Maulik, Pallab K.
AU - Mbachu, Ikechukwu Innocent
AU - McLaughlin, Susan A.
AU - McPhail, Steven M.
AU - Meles, Hadush Negash
AU - Mendoza, Walter
AU - Menezes, Ritesh G.
AU - Mengesha, Endalkachew Worku
AU - Mestrovic, Tomislav
AU - Mettananda, Sachith
AU - Mewoabi, Sandrine Donfack D.
AU - Michelerio, Andrea
AU - Miller, Ted R.
AU - Minervini, Giuseppe
AU - Mirghafourvand, Mojgan
AU - Mittal, Chaitanya
AU - Mohamed, Mona Gamal
AU - Mohamed, Nouh Saad
AU - Mohamed Ahmed, Khabab Abbasher Hussien
AU - Mohammad-Alizadeh-Charandabi, Sakineh
AU - Mohammadian-Hafshejani, Abdollah
AU - Mohammed, Shafiu
AU - Mokdad, Ali H.
AU - Molavi Vardanjani, Hossein
AU - Monasta, Lorenzo
AU - Moradi, Yousef
AU - Moreira, Rafael Silveira
AU - Motappa, Rohith
AU - Mozahheb Yousefi, Kimia
AU - Mubarik, Sumaira
AU - Mujica, Oscar J.
AU - Mullany, Erin C.
AU - Murray, Christopher J.L.
AU - Myung, Woojae
AU - Nagarajan, Karikalan
AU - Nargus, Shumaila
AU - Nashwan, Abdulqadir J.
AU - Nassar, Mahmoud
AU - Navaratna, Samidi Nirasha Kumari
AU - Nayak, Biswa Prakash
AU - Nayak, Shalini Ganesh
AU - Nazri-Panjaki, Athare
AU - Ndungu, Anthony Wainaina
AU - Nearchou, Finiki
AU - Nega, Amanuel Tebabal
AU - Negoi, Ionut
AU - Nguyen, Cao Duy
AU - Nguyen, Cuong Tat
AU - Nguyen, Huong Lan Thi
AU - Nguyen, Long
AU - Noor, Syed Toukir Ahmed
AU - Noreen, Mamoona
AU - Norouzy, Amir
AU - Nri-Ezedi, Chisom Adaobi
AU - Nwakama, Chijindu N.
AU - Nyande, Felix Kwasi
AU - O'Connell, Erin M.
AU - Okonji, Osaretin Christabel
AU - Okunlola, John Olayemi
AU - Olabisi, Oluwaseyi Isaiah
AU - Olorunsaiye, Comfort Z.
AU - Onie, Sandersan
AU - Onwujekwe, Obinna E.
AU - Orscelik, Atakan
AU - Ortiz-Prado, Esteban
AU - Osborne, Augustus
AU - Osuagwu, Uchechukwu Levi
AU - Ouyahia, Amel
AU - P A, Mahesh
AU - Padubidri, Jagadish Rao
AU - Palma-Alvarez, Raul Felipe
AU - Pantazopoulos, Ioannis
AU - Parikh, Romil R.
AU - Parmar, Arpit
AU - Pashaei, Ava
AU - Pasovic, Maja
AU - Patel, Jay
AU - Patel, Sangram Kishor
AU - Patil, Shankargouda
AU - Pawar, Shrikant
AU - Pawar, Shubhadarshini
AU - Peprah, Prince
AU - Poluru, Ramesh
AU - Pourtaheri, Naeimeh
AU - Pradhan, Jalandhar
AU - Prates, Elton Junio Sady
AU - Puthussery, Shuby
AU - Puvvula, Jagadeesh
AU - Qattea, Ibrahim
AU - Qi, Xiang
AU - Qi, Zhipeng
AU - Qiao, Yanan
AU - Raheem, Kabir Ayobami
AU - Rahimi-Movaghar, Vafa
AU - Rahman, Md Mosfequr
AU - Rahman, Mosiur
AU - Rahman, Muhammad Aziz
AU - Raimondo, Ivano
AU - Rajaa, Sathish
AU - Rajpoot, Pushp Lata
AU - Ramadan, Mahmoud Mohammed
AU - Ramazanu, Sheena
AU - Ranabhat, Chhabi Lal
AU - Rao, Sowmya J.
AU - Rathish, Devarajan
AU - Rauniyar, Santosh Kumar
AU - Rezaeian, Mohsen
AU - Rhee, Taeho Gregory
AU - Rodriguez, Jefferson Antonio Buendia
AU - Roever, Leonardo
AU - Ronfani, Luca
AU - Rony, Moustaq Karim Khan
AU - Ross, Allen Guy Patrick
AU - Rouzbahani, Hanieh
AU - Rouzbahani, Shiva
AU - Roy, Priyanka
AU - Roy, Sharmistha
AU - Rudolf, Robert
AU - Sabet, Cameron John
AU - Saeed, Mohd
AU - Saeed, Umar
AU - Sagar, Rajesh
AU - Sagoe, Dominic
AU - Sahoo, Pragyan Monalisa
AU - Sajadi, S. Mohammad
AU - Salihu, Dauda
AU - Sameen, Sonia
AU - Samy, Abdallah M.
AU - Santomauro, Damian F.
AU - Santric-Milicevic, Milena M.
AU - Sarkar, Tanmay
AU - Sarode, Gargi Sachin
AU - Sarode, Sachin C.
AU - Satpathy, Maheswar
AU - Sawhney, Monika
AU - Selvaraj, Siddharthan
AU - Sethi, Yashendra
AU - Shahab, Muhammad
AU - Shahid, Samiah
AU - Shahwan, Moyad Jamal
AU - Shaikh, Masood Ali
AU - Shaikh, Nafhat
AU - Shamsi, Anas
AU - Shamsutdinova, Alfiya
AU - Shan, Dan
AU - Shanawaz, Mohd
AU - Shannawaz, Mohammed
AU - Sharma, Vishal
AU - Shetty, Mahabalesh
AU - Shetty, Premalatha K.
AU - Shi, Wenming
AU - Shimul, Md Monir Hossain
AU - Shiri, Rahman
AU - Shittu, Aminu
AU - Shiue, Ivy
AU - Shorofi, Seyed Afshin
AU - Siddig, Emmanuel Edwar
AU - Silva, Gustavo Correia Basto da
AU - Singh, Akanksha
AU - Singh, Baljinder
AU - Sousa, Marco Aurelio
AU - Stanikzai, Muhammad Haroon
AU - Stein, Caroline
AU - Stein, Dan J.
AU - Stubbs, Brendon
AU - Subramaniyan, Vetriselvan
AU - Suhaib, Mahwish
AU - Sullman, Mark J.M.
AU - Sun, Jing
AU - Swain, Chandan Kumar
AU - Sree Sudha, T. Y.
AU - Tabarés-Seisdedos, Rafael
AU - Tabatabaei, Seyyed Mohammad
AU - Tabche, Celine
AU - Tampa, Mircea
AU - Tareke, Minale
AU - Taridashti, Sarvenaz
AU - Tasnim, Anika
AU - Temsah, Mohamad Hani
AU - Tesfu, Azimeraw Arega
AU - Thapar, Rekha
AU - Thiruvengadam, Muthu
AU - Tian, Wei
AU - Tovani-Palone, Marcos Roberto
AU - Tran, Tam Quoc Minh
AU - Tran, Thang Huu
AU - Tromans, Samuel Joseph
AU - Truppa, Claudia
AU - Tsai, Alexander C.
AU - Tsermpini, Evangelia Eirini
AU - Twalibu, Aisha
AU - Unnikrishnan, Bhaskaran
AU - Vally, Zahir
AU - Vasconcelos, Nadia Machado
AU - Vieira, Aliscia
AU - Villarreal-Zegarra, David
AU - Vinayak, Manish
AU - Vos, Theo
AU - Waheed, Yasir
AU - Walia, Megha
AU - Wang, Qingzhi
AU - Wang, Wei
AU - Wang, Yuan Pang
AU - Wickramasinghe, Nuwan Darshana
AU - Wiredu Agyekum, Martin
AU - Xie, Wanqing
AU - Xu, Wanqing
AU - Yahoo (Syed), Saba
AU - Yan, Guangcan
AU - Yang, Yuqi
AU - Ye, Pengpeng
AU - Yesodharan, Renjulal
AU - Yi, Siyan
AU - Yismaw, Yazachew Engida
AU - Yon, Dong Keon
AU - Yonemoto, Naohiro
AU - Yu, Chuanhua
AU - Yunusa, Umar
AU - Zadey, Siddhesh
AU - Zamagni, Giulia
AU - Zandam, Hussaini
AU - Zeariya, Mohammed G.M.
AU - Zemariam, Alemu Birara
AU - Zhang, Beijian
AU - Zhang, Haijun
AU - Zhumagaliuly, Abzal
AU - Zinchuk, Mikhail
AU - Zoromba, Mohamed Ali
AU - Zyoud, Sa'ed H.
AU - Gakidou, Emmanuela
N1 - Publisher Copyright: © 2026 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
PY - 2026/1/3
Y1 - 2026/1/3
N2 - Background Violence against women and against children are human rights violations with lasting harms to survivors and societies at large. Intimate partner violence (IPV) and sexual violence against children (SVAC) are two major forms of such abuse. Despite their wide-reaching effects on individual and community health, these risk factors have not been adequately prioritised as key drivers of global health burden. Comprehensive x§and reliable estimates of the comparative health burden of IPV and SVAC are urgently needed to inform investments in prevention and support for survivors at both national and global levels. Methods We estimated the prevalence and attributable burden of IPV among females and SVAC among males and females for 204 countries and territories, by age and sex, from 1990 to 2023, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. We searched several global databases for data on self-reported exposure to IPV and SVAC and undertook a systematic review to identify the health outcomes associated with each of these risk factors. We modelled IPV and SVAC prevalence using spatiotemporal Gaussian process regression, applying data adjustments to account for measurement heterogeneity. We employed burden-of-proof methodology to estimate relative risks for outcomes associated with IPV and SVAC. These estimates informed the calculation of population attributable fractions, which were then used to quantify disability-adjusted life-years (DALYs) attributable to each risk factor. Findings Globally, in 2023, we estimated that 608 million (95% uncertainty interval 518–724) females aged 15 years and older had ever been exposed to IPV, and 1·01 billion (0·764–1·48) individuals aged 15 years and older had experienced sexual violence during childhood. 18·5 million (8·74–30·0) DALYs were attributed to IPV among females and 32·2 million (16·4–52·5) DALYs were attributed to SVAC among males and females in 2023. IPV and SVAC were among the top contributors to the global disease burden in 2023, particularly among females aged 15–49 years, ranking as the fourth and fifth leading risk factors, respectively, for DALYs in this group. Among the eight health outcomes found to be associated with IPV, anxiety disorders and major depressive disorder were the leading causes of IPV-attributed DALYs, accounting for 5·43 million (–1·25 to 14·6) and 3·96 million (1·71 to 6·92) DALYs in 2023, respectively. SVAC was associated with 14 health outcomes, including mental health disorder, substance use disorder, and chronic and infectious disease outcomes. Self-harm and schizophrenia were the leading causes of SVAC-attributed burden, with SVAC accounting for 6·71 million (2·00 to 12·7) DALYs due to self-harm and 4·15 million (–1·92 to 13·1) DALYs due to schizophrenia in 2023. Interpretation IPV and SVAC are substantial contributors to global health burden, and their health consequences span a variety of individual health outcomes. Importantly, mental health disorders account for the greatest share of disease burden among survivors. Investing in prevention of these avoidable risk factors has the potential to avert millions of DALYs and considerable premature mortality each year. Our findings represent strong evidence for global and national leaders to elevate IPV and SVAC among public health priorities. Sustained investments are needed to prevent IPV and SVAC and to implement interventions focused on supporting the complex social and health needs of survivors. Funding Gates Foundation.
AB - Background Violence against women and against children are human rights violations with lasting harms to survivors and societies at large. Intimate partner violence (IPV) and sexual violence against children (SVAC) are two major forms of such abuse. Despite their wide-reaching effects on individual and community health, these risk factors have not been adequately prioritised as key drivers of global health burden. Comprehensive x§and reliable estimates of the comparative health burden of IPV and SVAC are urgently needed to inform investments in prevention and support for survivors at both national and global levels. Methods We estimated the prevalence and attributable burden of IPV among females and SVAC among males and females for 204 countries and territories, by age and sex, from 1990 to 2023, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. We searched several global databases for data on self-reported exposure to IPV and SVAC and undertook a systematic review to identify the health outcomes associated with each of these risk factors. We modelled IPV and SVAC prevalence using spatiotemporal Gaussian process regression, applying data adjustments to account for measurement heterogeneity. We employed burden-of-proof methodology to estimate relative risks for outcomes associated with IPV and SVAC. These estimates informed the calculation of population attributable fractions, which were then used to quantify disability-adjusted life-years (DALYs) attributable to each risk factor. Findings Globally, in 2023, we estimated that 608 million (95% uncertainty interval 518–724) females aged 15 years and older had ever been exposed to IPV, and 1·01 billion (0·764–1·48) individuals aged 15 years and older had experienced sexual violence during childhood. 18·5 million (8·74–30·0) DALYs were attributed to IPV among females and 32·2 million (16·4–52·5) DALYs were attributed to SVAC among males and females in 2023. IPV and SVAC were among the top contributors to the global disease burden in 2023, particularly among females aged 15–49 years, ranking as the fourth and fifth leading risk factors, respectively, for DALYs in this group. Among the eight health outcomes found to be associated with IPV, anxiety disorders and major depressive disorder were the leading causes of IPV-attributed DALYs, accounting for 5·43 million (–1·25 to 14·6) and 3·96 million (1·71 to 6·92) DALYs in 2023, respectively. SVAC was associated with 14 health outcomes, including mental health disorder, substance use disorder, and chronic and infectious disease outcomes. Self-harm and schizophrenia were the leading causes of SVAC-attributed burden, with SVAC accounting for 6·71 million (2·00 to 12·7) DALYs due to self-harm and 4·15 million (–1·92 to 13·1) DALYs due to schizophrenia in 2023. Interpretation IPV and SVAC are substantial contributors to global health burden, and their health consequences span a variety of individual health outcomes. Importantly, mental health disorders account for the greatest share of disease burden among survivors. Investing in prevention of these avoidable risk factors has the potential to avert millions of DALYs and considerable premature mortality each year. Our findings represent strong evidence for global and national leaders to elevate IPV and SVAC among public health priorities. Sustained investments are needed to prevent IPV and SVAC and to implement interventions focused on supporting the complex social and health needs of survivors. Funding Gates Foundation.
UR - https://www.scopus.com/pages/publications/105026618723
U2 - 10.1016/S0140-6736(25)02503-6
DO - 10.1016/S0140-6736(25)02503-6
M3 - Article
C2 - 41386261
AN - SCOPUS:105026618723
SN - 0140-6736
VL - 407
SP - 31
EP - 52
JO - The Lancet
JF - The Lancet
IS - 10523
ER -